Sign In
Buy BIIB
$207.94
+1.66 (+0.80%)
At Close: Aug 07, 2026
Biogen Ends Development of Alzheimer's Drug Aduhelm
08:55am, Wednesday, 31'st Jan 2024
The biotechnology company says it will record a one-time charge of about $60 million related to close-out costs.
Biogen halts development of controversial Alzheimer's drug
07:54am, Wednesday, 31'st Jan 2024
Biogen Inc. BIIB, -0.18% said Wednesday that it will halt the development and commercialization of its Alzheimer's drug Aduhelm, which drew intense scrutiny of its U.S. regulatory approval process due
Biogen Inc. (BIIB) Laps the Stock Market: Here's Why
06:56pm, Monday, 29'th Jan 2024
Biogen Inc. (BIIB) closed at $247.52 in the latest trading session, marking a +1.1% move from the prior day.
Will Biogen Inc. (BIIB) Beat Estimates Again in Its Next Earnings Report?
01:11pm, Monday, 29'th Jan 2024
Biogen Inc. (BIIB) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Biogen Inc. (BIIB) Rises Higher Than Market: Key Facts
06:56pm, Tuesday, 23'rd Jan 2024
Biogen Inc. (BIIB) closed the most recent trading day at $251.68, moving +1.36% from the previous trading session.
These Could Be the Biggest Nasdaq-100 Winners in 2024, According to Wall Street
05:50am, Thursday, 18'th Jan 2024
Two of Wall Street's favorite Nasdaq-100 stocks for 2024 are communications and media giants. The third stock that analysts think will soar this year is a biotech with a promising new drug on the mark
Time to Load Up on This New Magnificent 7 of ‘Strong Buy' Stocks
12:26pm, Friday, 12'th Jan 2024
Wall Street analysts tend to always look on the bright side of life. (Cue the Monty Python song).
Biogen Inc. (BIIB) Registers a Bigger Fall Than the Market: Important Facts to Note
07:37pm, Tuesday, 09'th Jan 2024
In the latest trading session, Biogen Inc. (BIIB) closed at $255.84, marking a -0.83% move from the previous day.
China approves Alzheimer's treatment Leqembi by Eisai and Biogen
05:19am, Tuesday, 09'th Jan 2024
Eisai and Biogen said on Tuesday that their Alzheimer's treatment Leqembi had won approval in China, the third country after the United States and Japan.
2 low-priced gene therapy stocks to speculate on
08:26am, Monday, 08'th Jan 2024
Gene therapy differs from gene editing, which is getting the lion's share of headlines. While gene editing is a form of gene therapy, there are basic differences.
Biogen Inc. (BIIB) Sees a More Significant Dip Than Broader Market: Some Facts to Know
07:33pm, Wednesday, 03'rd Jan 2024
In the latest trading session, Biogen Inc. (BIIB) closed at $263.43, marking a -1.6% move from the previous day.
Biogen Inc. (BIIB) Stock Declines While Market Improves: Some Information for Investors
07:35pm, Thursday, 28'th Dec 2023
The latest trading day saw Biogen Inc. (BIIB) settling at $260.58, representing a -0.52% change from its previous close.
Healthcare Heroes: 3 Stocks Innovating in Medicine and Wellness
05:31pm, Wednesday, 27'th Dec 2023
The United States leads globally in the healthcare sector, with its innovative healthcare stocks drawing attention from an impressive $4.3 trillion in spending. As the American Medical Association hig
Top 3 Healthcare Stock Picks for the New Year
08:14pm, Monday, 25'th Dec 2023
After lagging most sectors in 2023, healthcare stocks could deliver substantial returns in 2024. The market has been overly pessimistic about the sector due to short-term challenges.
Election noise may make pharmaceutical stocks 'untenable' for investors, says Mizuho's Jared Holz
02:50pm, Wednesday, 20'th Dec 2023
Jared Holz, Mizuho healthcare sector specialist, joins 'The Exchange' to discuss the 2024 outlook for health care, which stocks to buy in the new year, and more.
